Mark Halvorson

Array ( [id] => 3868846 [patent_doc_number] => 05837673 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Camptothecin derivatives' [patent_app_type] => 1 [patent_app_number] => 8/689018 [patent_app_country] => US [patent_app_date] => 1996-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25533 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837673.pdf [firstpage_image] =>[orig_patent_app_number] => 689018 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3927353 [patent_doc_number] => 05877147 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-02 [patent_title] => 'Compounds for medicinal use' [patent_app_type] => 1 [patent_app_number] => 8/624592 [patent_app_country] => US [patent_app_date] => 1996-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5650 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/877/05877147.pdf [firstpage_image] =>[orig_patent_app_number] => 624592 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1494344 [patent_doc_number] => 06403304 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-11 [patent_title] => 'Human osteoclast-specific and -related DNA sequences' [patent_app_type] => B1 [patent_app_number] => 08/684932 [patent_app_country] => US [patent_app_date] => 1996-07-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 14777 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/403/06403304.pdf [firstpage_image] =>[orig_patent_app_number] => 08684932 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3771158 [patent_doc_number] => 05756462 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-26 [patent_title] => 'Pore forming peptides from Geolycosa riogrande' [patent_app_type] => 1 [patent_app_number] => 8/682621 [patent_app_country] => US [patent_app_date] => 1996-07-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2927 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/756/05756462.pdf [firstpage_image] =>[orig_patent_app_number] => 682621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4406804 [patent_doc_number] => 06300079 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-10-09 [patent_title] => 'Polypeptide and process for measuring living body components using the same' [patent_app_type] => 1 [patent_app_number] => 8/680855 [patent_app_country] => US [patent_app_date] => 1996-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 27773 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/300/06300079.pdf [firstpage_image] =>[orig_patent_app_number] => 680855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3686572 [patent_doc_number] => 05663150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-02 [patent_title] => 'Cyclopentane-.beta.-amino acid tripeptides' [patent_app_type] => 1 [patent_app_number] => 8/679038 [patent_app_country] => US [patent_app_date] => 1996-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3255 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 83 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/663/05663150.pdf [firstpage_image] =>[orig_patent_app_number] => 679038 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3743811 [patent_doc_number] => 05801150 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-09-01 [patent_title] => 'Aminopyri(mi)dine derivatives combined with amino acids, and pharmacological activities thereof' [patent_app_type] => 1 [patent_app_number] => 8/571832 [patent_app_country] => US [patent_app_date] => 1996-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4285 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 230 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/801/05801150.pdf [firstpage_image] =>[orig_patent_app_number] => 571832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4088936 [patent_doc_number] => 06133229 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-17 [patent_title] => 'Stabilization of proteins in solution' [patent_app_type] => 1 [patent_app_number] => 8/624585 [patent_app_country] => US [patent_app_date] => 1996-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3847 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 192 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/133/06133229.pdf [firstpage_image] =>[orig_patent_app_number] => 624585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4248623 [patent_doc_number] => 06221838 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Methods of treating neuropeptide Y-associated conditions' [patent_app_type] => 1 [patent_app_number] => 8/674774 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 35968 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 584 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221838.pdf [firstpage_image] =>[orig_patent_app_number] => 674774 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4126601 [patent_doc_number] => 06127337 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-10-03 [patent_title] => 'Bivalent thrombin inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/636698 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 18792 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 318 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/127/06127337.pdf [firstpage_image] =>[orig_patent_app_number] => 636698 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769888 [patent_doc_number] => 05733883 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Crystallization of .alpha.-L-aspartyl-L-phenylalanine methyl ester from aqueous solution' [patent_app_type] => 1 [patent_app_number] => 8/672924 [patent_app_country] => US [patent_app_date] => 1996-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5426 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733883.pdf [firstpage_image] =>[orig_patent_app_number] => 672924 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4013765 [patent_doc_number] => 05880095 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents' [patent_app_type] => 1 [patent_app_number] => 8/666300 [patent_app_country] => US [patent_app_date] => 1996-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 7469 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880095.pdf [firstpage_image] =>[orig_patent_app_number] => 666300 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4295144 [patent_doc_number] => 06197745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-03-06 [patent_title] => 'Methods for producing nitrosated hemoglobins and therapeutic uses therefor' [patent_app_type] => 1 [patent_app_number] => 8/667003 [patent_app_country] => US [patent_app_date] => 1996-06-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 30 [patent_no_of_words] => 15754 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/197/06197745.pdf [firstpage_image] =>[orig_patent_app_number] => 667003 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4370445 [patent_doc_number] => 06288037 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-09-11 [patent_title] => 'Substrates and inhibitors for cysteine protease ICH-1' [patent_app_type] => 1 [patent_app_number] => 8/665643 [patent_app_country] => US [patent_app_date] => 1996-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18857 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/288/06288037.pdf [firstpage_image] =>[orig_patent_app_number] => 665643 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3723654 [patent_doc_number] => 05672586 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-09-30 [patent_title] => 'Herpes ribonucleotide reductase inhibitors' [patent_app_type] => 1 [patent_app_number] => 8/666732 [patent_app_country] => US [patent_app_date] => 1996-06-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 13084 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/672/05672586.pdf [firstpage_image] =>[orig_patent_app_number] => 666732 [rel_patent_id] =>[rel_patent_doc_number] =>)